nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract
|
Braybrooke, J.P. |
|
|
8 |
3 |
p. 294-296 |
artikel |
2 |
A phase II study of mitomycin C and oral etoposide for advancedadenocarcinoma of the upper gastrointestinal tract
|
J. P. Braybrooke |
|
1997 |
8 |
3 |
p. 294-296 3 p. |
artikel |
3 |
Awards, appointments
|
|
|
|
8 |
3 |
p. 213 |
artikel |
4 |
Bone marrow and peripheral blood stem cell transplantation in multiple myeloma
|
Gahrton, Gösta |
|
|
8 |
3 |
p. 219-221 |
artikel |
5 |
Bone marrow and peripheral blood stem cell transplantation in multiple myeloma
|
Gösta Gahrton |
|
1997 |
8 |
3 |
p. 219-221 3 p. |
artikel |
6 |
Book review
|
Cavalli, F. |
|
|
8 |
3 |
p. 214 |
artikel |
7 |
Book review
|
Cerottini, J.-C. |
|
|
8 |
3 |
p. 222 |
artikel |
8 |
Bookreviews
|
J-C. Cerrotini |
|
1997 |
8 |
3 |
p. 222-222 1 p. |
artikel |
9 |
Case history: A step up the analgesic ladder
|
M. Zenz |
|
1997 |
8 |
3 |
p. 25-26 2 p. |
artikel |
10 |
Case history 2: The use of epoetin alfa before high-dosechemotherapy
|
R. Mertelsmann |
|
1997 |
8 |
3 |
p. 13-13 1 p. |
artikel |
11 |
Case history 1: The use of epoetin alfa in delayed anaemia
|
R. Mertelsmann |
|
1997 |
8 |
3 |
p. 11-12 2 p. |
artikel |
12 |
Cisplatin-paclitaxel weekly schedule in advanced solid tumors: A phase I study
|
Frasci, G. |
|
|
8 |
3 |
p. 291-293 |
artikel |
13 |
Cisplatinpaclitaxel weekly schedule in advanced solid tumors: A phase I study
|
G. Frasci |
|
1997 |
8 |
3 |
p. 291-293 3 p. |
artikel |
14 |
Contents of the next issue
|
|
|
|
8 |
3 |
p. v |
artikel |
15 |
Copyright
|
|
|
|
8 |
3 |
p. iii |
artikel |
16 |
Current strategies for pain control
|
S. Ahmedzai |
|
1997 |
8 |
3 |
p. 21-24 4 p. |
artikel |
17 |
Detection of occult gastric carcinoma with Indium-111 labeled CYT-103 (Oncoscint) immunoscintigraphy
|
Kruglyak, E. |
|
|
8 |
3 |
p. 301-302 |
artikel |
18 |
Detection of occult gastric carcinoma with Indium-111 labeled CYT-103 (Oncoscint) immunoscintigraphy
|
E. Kruglyak |
|
1997 |
8 |
3 |
p. 301-302 2 p. |
artikel |
19 |
Eating to beat breast cancer: Potential role for soy supplements
|
Stoll, B.A. |
|
|
8 |
3 |
p. 223-225 |
artikel |
20 |
Eating to beat breast cancer: Potential role for soy supplements
|
B. A. Stoll |
|
1997 |
8 |
3 |
p. 223-225 3 p. |
artikel |
21 |
Editorial Board
|
|
|
|
8 |
3 |
p. iv |
artikel |
22 |
Foreword
|
R. Mertelsmann |
|
1997 |
8 |
3 |
p. 1-1 1 p. |
artikel |
23 |
Haematological toxicities associated with dose-intensive chemotherapy,the role for and use of recombinant growth factors
|
D. Henry |
|
1997 |
8 |
3 |
p. 7-10 4 p. |
artikel |
24 |
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
|
Goldschmidt, H. |
|
|
8 |
3 |
p. 243-246 |
artikel |
25 |
High-dose therapy with peripheral blood progenitor cell transplantationin multiple myeloma
|
H. Goldschmidt |
|
1997 |
8 |
3 |
p. 243-246 4 p. |
artikel |
26 |
5HT3 antagonists and radiotherapy
|
Mitchell, G. |
|
|
8 |
3 |
p. 302 |
artikel |
27 |
5HT_3 antagonists and radiotherapy
|
G. Mitchell |
|
1997 |
8 |
3 |
p. 302-302 1 p. |
artikel |
28 |
Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial
|
Beller, E. |
|
|
8 |
3 |
p. 277-283 |
artikel |
29 |
Improved quality of life with megestrol acetate in patients withendocrine-insensitive advanced cancer: A randomised placebo-controlledtrial
|
E. Beller |
|
1997 |
8 |
3 |
p. 277-283 7 p. |
artikel |
30 |
In most of Central America access to oncology is still limited
|
|
|
|
8 |
3 |
p. 211-213 |
artikel |
31 |
In this issue
|
|
|
|
8 |
3 |
p. v |
artikel |
32 |
Lymphadenopathy due to amyloid deposition in non-Hodgkin’s lymphoma
|
Simmonds, P.D. |
|
|
8 |
3 |
p. 267-270 |
artikel |
33 |
Lymphadenopathy due to amyloid deposition in non-Hodgkins lymphoma
|
P. D. Simmonds |
|
1997 |
8 |
3 |
p. 267-270 4 p. |
artikel |
34 |
News
|
Steven Dickman |
|
1997 |
8 |
3 |
p. 209-214 6 p. |
artikel |
35 |
PACE BOM chemotherapy: A 12-week regimen for advanced Hodgkin’s disease
|
Simmonds, P.D. |
|
|
8 |
3 |
p. 259-266 |
artikel |
36 |
PACE BOM chemotherapy: A 12-week regimen for advanced Hodgkinsdisease
|
P. D. Simmonds |
|
1997 |
8 |
3 |
p. 259-266 8 p. |
artikel |
37 |
‘Patching’ embroyonic development to cancer
|
|
|
|
8 |
3 |
p. 209-214 |
artikel |
38 |
Perhaps not everyone knows that…
|
|
|
|
8 |
3 |
p. 213-214 |
artikel |
39 |
Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine
|
Fopp, M. |
|
|
8 |
3 |
p. 251-257 |
artikel |
40 |
Post-remission therapy of adult acute myeloid leukaemia: One cycle ofhigh-dose versus standard-dose cytarabine
|
M. Fopp |
|
1997 |
8 |
3 |
p. 251-257 7 p. |
artikel |
41 |
Quote/unquote
|
|
|
|
8 |
3 |
p. 213 |
artikel |
42 |
Radiation therapy following breast conservation surgery: Can it ever be avoided?
|
Whelan, T. |
|
|
8 |
3 |
p. 217-218 |
artikel |
43 |
Radiation therapy following breast conservation surgery: Can it ever be avoided?
|
T. Whelan |
|
1997 |
8 |
3 |
p. 217-218 2 p. |
artikel |
44 |
Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF
|
Fox, S.B. |
|
|
8 |
3 |
p. 271-275 |
artikel |
45 |
Relationship of elevated tumour thymidine phosphorylase in node-positivebreast carcinomas to the effects of adjuvant CMF
|
S. B. Fox |
|
1997 |
8 |
3 |
p. 271-275 5 p. |
artikel |
46 |
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy
|
Liljegren, G. |
|
|
8 |
3 |
p. 235-241 |
artikel |
47 |
Risk factors for local recurrence after conservative treatment in stageI breast cancer. Definition of a subgroup not requiring radiotherapy
|
G. Liljegren |
|
1997 |
8 |
3 |
p. 235-241 7 p. |
artikel |
48 |
Risk of breast cancer subsequent to histological or clinical diagnosis of fibroadenoma - retrospective longitudinal study of 3938 cases
|
Ciatto, S. |
|
|
8 |
3 |
p. 297-300 |
artikel |
49 |
Risk of breast cancer subsequent to histological or clinical diagnosisof fibroadenoma retrospective longitudinal study of 3938 cases
|
S. Ciatto |
|
1997 |
8 |
3 |
p. 297-300 4 p. |
artikel |
50 |
Table of Contents
|
|
|
|
8 |
3 |
p. ii-iii |
artikel |
51 |
The advancement of high-dose chemotherapy and dose intensificationschedules
|
R. C. F. Leonard |
|
1997 |
8 |
3 |
p. 3-6 4 p. |
artikel |
52 |
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature
|
Reni, M. |
|
|
8 |
3 |
p. 227-234 |
artikel |
53 |
Therapeutic management of primary central nervous system lymphoma inimmunocompetent patients: Results of a critical review of the literature
|
M. Reni |
|
1997 |
8 |
3 |
p. 227-234 8 p. |
artikel |
54 |
The systemic treatment of non-small-cell lung cancer
|
Propper, D. |
|
|
8 |
3 |
p. 285-290 |
artikel |
55 |
The systemic treatment of non-small-cell lung cancer
|
D. Propper |
|
1997 |
8 |
3 |
p. 285-290 5 p. |
artikel |
56 |
The therapy of cancer pain and its integration into a comprehensivesupportive care strategy
|
M. Kjaer |
|
1997 |
8 |
3 |
p. 15-19 5 p. |
artikel |
57 |
This letter was referred to the author, who responds as follows:
|
Aapro, M.S. |
|
|
8 |
3 |
p. 302 |
artikel |
58 |
This letter was referred to the author, who responds as follows:
|
M.S. Aapro |
|
1997 |
8 |
3 |
p. 302-302 1 p. |
artikel |
59 |
Treatment of childhood Hodgkin’s disease with chemotherapy alone
|
Hudson, M.M. |
|
|
8 |
3 |
p. 215-216 |
artikel |
60 |
Treatment of childhood Hodgkins disease with chemotherapy alone
|
m.M. Hudson |
|
1997 |
8 |
3 |
p. 215-216 2 p. |
artikel |
61 |
Treatment of childhood Hodgkin’s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua
|
Baez, F. |
|
|
8 |
3 |
p. 247-250 |
artikel |
62 |
Treatment of childhood Hodgkins disease with COPP or COPP-ABV (hybrid)without radiotherapy in Nicaragua
|
F. Baez |
|
1997 |
8 |
3 |
p. 247-250 4 p. |
artikel |
63 |
US panel fails to recommend mammography screening for women under the age of 50
|
|
|
|
8 |
3 |
p. 210-211 |
artikel |